You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Roche scores EU approval for at-home SMA treatment Evrysdi

The European Commission (EC) has approved Roche’s spinal muscular atrophy (SMA) treatment Evrysdi for use in patients aged two months and older.